Peptide Nucleic Acid Probes for Pathogen Detection Without PCR

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current pathogen detection methods lack specificity and robustness for use outside laboratory settings, relying on PCR for nucleic acid amplification and antibody recognition, which are not suitable for field applications.

Innovation Solution

The use of peptide nucleic acids (PNAs) with cross-reactive functional groups and reporter molecules for direct detection of nucleic acids, forming a covalent bond on a substrate to enhance specificity and stability, allowing for visual detection of pathogens like anthrax, avian flu, and HIV without the need for PCR.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If PCR is used to amplify target sequences, then detection sensitivity is improved, but device complexity and requirement for laboratory environment increase

Engineering Contradiction:
Improvedetection sensitivityVSAvoiddevice complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The invention extracts and eliminates the PCR amplification step from the detection system, using PNA-based hybridization alone to achieve detection. This removes the complex enzymatic amplification machinery while maintaining sensitivity through the high affinity and specificity of PNA-DNA binding, enabling simpler devices suitable for field use

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention changes the fundamental detection parameter from amplification-based to hybridization-based detection. By using PNA probes with enhanced binding characteristics (higher affinity and specificity than traditional DNA probes), the system achieves sufficient sensitivity without requiring signal amplification through PCR, thus simplifying the overall device complexity

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If antibody recognition is used for pathogen detection, then ease of operation is improved, but detection specificity deteriorates

Engineering Contradiction:
Improveease of operationVSAvoiddetection specificity
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The invention uses PNA, a composite molecule with properties of both peptides and nucleic acids, as the detection probe. PNA combines the stability and ease of handling of peptides with the sequence-specific binding capability of nucleic acids, achieving both ease of operation and high detection specificity that neither antibodies nor traditional DNA probes can provide alone

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The invention introduces cross-reactive functional groups at specific locations on the PNA molecule to create localized binding sites. This allows the PNA to maintain high sequence specificity through its nucleic acid-like binding region while incorporating functional groups that enhance stability and ease of operation, achieving both specificity and operational simplicity

Inventive Principle:
Principle #3Local quality

3Ease of manufacture

If traditional DNA probes are used, then ease of manufacture is improved, but sequence specificity and stability deteriorate

Engineering Contradiction:
Improveease of manufactureVSAvoidsequence specificity
Core Design Contradiction:
Ease of manufactureVSMeasurement precision

Solution Approach 1:

The invention changes the chemical composition parameter of the probe from traditional DNA to PNA, which has a peptide-like backbone instead of a sugar-phosphate backbone. This structural change confers enhanced stability (resistance to nucleases and chemical degradation) and improved sequence specificity (higher binding affinity and mismatch discrimination) while maintaining synthetic feasibility through established peptide synthesis methods

Inventive Principle:
Principle #35Parameter changes

4Measurement precision

If PNA with cross-reactive functional groups is used, then detection specificity is improved, but manufacturing complexity increases

Engineering Contradiction:
Improvedetection specificityVSAvoidease of manufacture
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The invention incorporates cross-reactive functional groups during the PNA synthesis process itself, rather than adding them as separate post-synthesis modifications. This preliminary incorporation of functional groups (such as biotin or other tags) into the PNA backbone during solid-phase synthesis simplifies the overall manufacturing process by combining probe synthesis and functionalization into a single step, reducing subsequent purification and modification steps

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method significantly improves detection specificity and sensitivity, reducing the detection limit by six orders of magnitude and enabling visual detection of pathogens, making it suitable for field use with improved sequence specificity and stability compared to traditional DNA probes.

Implementation Method 1

the first PNA has a reporter molecule attached thereto and the first and second PNAs being complementary to different portions of a target DNA

Methodology Applied
Scientific EffectHybridization:

Implementation Method 2

forming a covalent bond on a substrate to enhance specificity and stability

Methodology Applied
Scientific EffectCovalent bonding: Chemical Bonding

Implementation Method 3

The substrate can be washed prior to determining the presence of said reporter molecule. The substrate is visually observed to detect the appearance of color from the reporter molecule

Methodology Applied
Scientific EffectColor change:

Data Source

PatentUS9156778B2Cross-coupled peptide nucleic acids for detection of nucleic acids of pathogens
Publication Date: 2015.10.13 THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES
  • US9156778B2 patent drawing
  • US9156778B2 patent drawing
  • US9156778B2 patent drawing

AI summary

Disclosed is a method for lowering the detection limit in a method of detecting a nucleic acid comprising (i) contacting a solution comprising a first PNA with a substrate having a second PNA affixed thereto, the second PNA comprising at least one trans-cyclopentane residue, wherein the first PNA has two linker-attached biotins attached thereto and the first and second PNAs being complementary to different portions of a target DNA; (ii) contacting a sample suspected of containing the nucleic acid with the first and second PNAs; and (iii) determining the presence of the reporter molecule on the substrate. Also disclosed are a detection assay and a kit for detecting a target nucleic acid.